BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 31787695)

  • 1. Estimation of the Effectiveness of Quadrivalent Influenza Vaccines by Distinguishing Between Influenza A (H1N1) pdm09 and Influenza A (H3N2) Using Rapid Influenza Diagnostic Tests During the 2018-2019 Season.
    Ando S
    Intern Med; 2020 Apr; 59(7):933-940. PubMed ID: 31787695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
    Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
    Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderate influenza vaccine effectiveness against influenza A(H1N1)pdm09 virus and low effectiveness against A(H3N2) virus among older adults during 2013-2014 influenza season in Beijing, China.
    Zhang L; Pan Y; Ma C; Duan W; Sun Y; Wu S; Zhang M; Tian Y; Zheng Y; Yang P; Wang Q
    Hum Vaccin Immunother; 2018 Jun; 14(6):1323-1330. PubMed ID: 29461909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccine effectiveness against influenza A in children based on the results of various rapid influenza tests in the 2018/19 season.
    Shinjoh M; Sugaya N; Yamaguchi Y; Ookawara I; Nakata Y; Narabayashi A; Furuichi M; Yoshida N; Kamei A; Kuramochi Y; Shibata A; Shimoyamada M; Nakazaki H; Maejima N; Yuasa E; Araki E; Maeda N; Ohnishi T; Nishida M; Taguchi N; Yoshida M; Tsunematsu K; Shibata M; Hirano Y; Sekiguchi S; Kawakami C; Mitamura K; Takahashi T
    PLoS One; 2021; 16(3):e0249005. PubMed ID: 33770132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
    Wu S; Pan Y; Zhang X; Zhang L; Duan W; Ma C; Zhang Y; Zhang M; Sun Y; Yang P; Wang Q; Ma J
    Vaccine; 2018 Sep; 36(38):5774-5780. PubMed ID: 30087046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy.
    Bellino S; Bella A; Puzelli S; Di Martino A; Facchini M; Punzo O; Pezzotti P; Castrucci MR; The InfluNet Study Group
    Expert Rev Vaccines; 2019 Nov; 18(11):1201-1209. PubMed ID: 31674847
    [No Abstract]   [Full Text] [Related]  

  • 8. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
    J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
    Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
    Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19.
    Pebody RG; Whitaker H; Ellis J; Andrews N; Marques DFP; Cottrell S; Reynolds AJ; Gunson R; Thompson C; Galiano M; Lackenby A; Robertson C; O'Doherty MG; Owens K; Yonova I; Shepherd SJ; Moore C; Johnston J; Donati M; McMenamin J; Lusignan S; Zambon M
    Vaccine; 2020 Jan; 38(3):489-497. PubMed ID: 31685296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations - Latin America, 2013.
    El Omeiri N; Azziz-Baumgartner E; Thompson MG; ; Clará W; Cerpa M; Palekar R; Mirza S; Ropero-Álvarez AM
    Vaccine; 2018 Jun; 36(24):3555-3566. PubMed ID: 28648543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
    Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
    Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014/15 and 2015/16.
    Yaron-Yakoby H; Sefty H; Pando R; Dichtiar R; Katz MA; Stein Y; Mandelboim M; Mendelson E; Shohat T; Glatman-Freedman A;
    Euro Surveill; 2018 Feb; 23(7):. PubMed ID: 29471622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019.
    Mouratidou E; Lambrou A; Andreopoulou A; Gioula G; Exindari M; Kossyvakis A; Pogka V; Mentis A; Georgakopoulou T; Lytras T
    Vaccine; 2020 Mar; 38(12):2715-2724. PubMed ID: 32033848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18.
    Pebody R; Djennad A; Ellis J; Andrews N; Marques DFP; Cottrell S; Reynolds AJ; Gunson R; Galiano M; Hoschler K; Lackenby A; Robertson C; O'Doherty M; Sinnathamby M; Panagiotopoulos N; Yonova I; Webb R; Moore C; Donati M; Sartaj M; Shepherd SJ; McMenamin J; de Lusignan S; Zambon M
    Euro Surveill; 2019 Aug; 24(31):. PubMed ID: 31387673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011.
    Savulescu C; Jiménez-Jorge S; Delgado-Sanz C; de Mateo S; Pozo F; Casas I; Larrauri A;
    Vaccine; 2014 Jul; 32(35):4404-4411. PubMed ID: 24968153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children.
    Kissling E; Valenciano M; Pozo F; Vilcu AM; Reuss A; Rizzo C; Larrauri A; Horváth JK; Brytting M; Domegan L; Korczyńska M; Meijer A; Machado A; Ivanciuc A; Višekruna Vučina V; van der Werf S; Schweiger B; Bella A; Gherasim A; Ferenczi A; Zakikhany K; O Donnell J; Paradowska-Stankiewicz I; Dijkstra F; Guiomar R; Lazar M; Kurečić Filipović S; Johansen K; Moren A;
    Influenza Other Respir Viruses; 2018 Jul; 12(4):423-437. PubMed ID: 29125681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre study.
    Kissling E; Pozo F; Martínez-Baz I; Buda S; Vilcu AM; Domegan L; Mazagatos C; Dijkstra F; Latorre-Margalef N; Kurečić Filipović S; Machado A; Lazar M; Casado I; Dürrwald R; van der Werf S; O'Donnell J; Linares Dopido JA; Meijer A; Riess M; Višekruna Vučina V; Rodrigues AP; Mihai ME; Castilla J; Goerlitz L; Falchi A; Connell J; Castrillejo D; Hooiveld M; Carnahan A; Ilić M; Guiomar R; Ivanciuc A; Maurel M; Omokanye A; Valenciano M;
    Influenza Other Respir Viruses; 2023 Jan; 17(1):e13069. PubMed ID: 36702797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.
    Maurel M; Pozo F; Pérez-Gimeno G; Buda S; Sève N; Oroszi B; Hooiveld M; Gomez V; Domegan L; Martínez-Baz I; Ilić M; Carnahan AS; Mihai ME; Martínez A; Goerlitz L; Enouf V; Horváth JK; Dijkstra F; Rodrigues AP; Bennett C; Trobajo-Sanmartín C; Mlinarić I; Latorre-Margalef N; Ivanciuc A; Lopez A; Dürrwald R; Falchi A; Túri G; Meijer A; Melo A; O'Donnell J; Castilla J; Vučina VV; Hagey TS; Lazar M; Kaczmarek M; Bacci S; Kissling E;
    Influenza Other Respir Viruses; 2024 Jan; 18(1):e13243. PubMed ID: 38204584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
    J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.